Element25 Completes Scoping Study for Tokyo Bay HPMSM Facility

2025-04-03 12:20:00 ET

Element25 ( ASX : E25 , OTCQX:ELMTF ) said on Wednesday (April 2) that it has completed a scoping study for its planned Tokyo Bay high-purity manganese sulphate monohydrate (HPMSM) facility in Japan.

The study was completed as part of Element25's memorandum of understanding (MOU) with Nissan Chemical (TSE: 4021 ) and its subsidiary, NC Tokyo Bay. It confirms the facility's feasibility, with no fatal flaws detected.

Factors included in the study are permitting, logistics, reagent supply and labour, plus capital and operating costs. The facility is set to be located at an existing site owned by NC Tokyo Bay in Chiba prefecture, Japan.

For further details see: